155 related articles for article (PubMed ID: 31920434)
1. The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers.
Abadelah M; Al-Assadi J; Rooney J; Larhrib H
Saudi Pharm J; 2020 Jan; 28(1):74-86. PubMed ID: 31920434
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
3. Study of the Emitted Dose After Two Separate Inhalations at Different Inhalation Flow Rates and Volumes and an Assessment of Aerodynamic Characteristics of Indacaterol Onbrez Breezhaler
Abadelah M; Chrystyn H; Bagherisadeghi G; Abdalla G; Larhrib H
AAPS PharmSciTech; 2018 Jan; 19(1):251-261. PubMed ID: 28695328
[TBL] [Abstract][Full Text] [Related]
4. Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler.
Abadelah M; Chrystyn H; Larhrib H
Eur J Pharm Sci; 2019 Jun; 134():138-144. PubMed ID: 31005623
[TBL] [Abstract][Full Text] [Related]
5. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
[TBL] [Abstract][Full Text] [Related]
6. Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.
Boshra MS; Almeldien AG; Salah Eldin R; Elberry AA; Abdelwahab NS; Nabil Salem M; Rabea H; Abdelrahim MEA
Exp Lung Res; 2018; 44(4-5):211-216. PubMed ID: 30346848
[TBL] [Abstract][Full Text] [Related]
7. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
[TBL] [Abstract][Full Text] [Related]
8. The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions.
Farkas Á; Tomisa G; Kugler S; Nagy A; Vaskó A; Kis E; Szénási G; Gálffy G; Horváth A
Int J Pharm X; 2023 Dec; 5():100167. PubMed ID: 36824288
[TBL] [Abstract][Full Text] [Related]
9. Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers.
Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):223-230. PubMed ID: 33147100
[No Abstract] [Full Text] [Related]
10. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
11. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
[TBL] [Abstract][Full Text] [Related]
12. Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler.
Abadelah M; Hazim F; Chrystyn H; Bagherisadeghi G; Rahmoune H; Larhrib H
Eur J Pharm Sci; 2017 Jun; 104():180-187. PubMed ID: 28351669
[TBL] [Abstract][Full Text] [Related]
13. Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza.
Murasaka T; Ikemura K; Enokiya T; Muraki Y; Ikemura M; Terada K; Iwamoto T; Okuda M
J Pharm Health Care Sci; 2017; 3():26. PubMed ID: 29152321
[TBL] [Abstract][Full Text] [Related]
14. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
Broeders ME; Molema J; Burnell PK; Folgering HT
J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
[TBL] [Abstract][Full Text] [Related]
15. Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection.
Farkas Á; Szipőcs A; Horváth A; Horváth I; Gálffy G; Varga J; Galambos K; Kugler S; Nagy A; Szalai Z
Respir Med; 2019; 154():133-140. PubMed ID: 31252206
[TBL] [Abstract][Full Text] [Related]
16. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
Broeders ME; Molema J; Hop WC; Folgering HT
J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.
Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Patzlaff A; Weimann B
J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):156-163. PubMed ID: 30848695
[No Abstract] [Full Text] [Related]
18. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.
Mahler DA; Demirel S; Hollander R; Gopalan G; Shaikh A; Mahle CD; Elder J; Morrison C
Chronic Obstr Pulm Dis; 2022 Jul; 9(3):427-438. PubMed ID: 35788259
[TBL] [Abstract][Full Text] [Related]
19. Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
Tajiri S; Kondo T; Tanigaki T; Hibino M; Asano K
Respir Med; 2022 Sep; 201():106950. PubMed ID: 35963030
[TBL] [Abstract][Full Text] [Related]
20. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
